Quarterly report pursuant to Section 13 or 15(d)

LICENSE/SUPPLIER AGREEMENT (Details Narrative)

v3.24.2.u1
LICENSE/SUPPLIER AGREEMENT (Details Narrative) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
May 16, 2022
Oct. 31, 2020
Aug. 31, 2020
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Revenue recognized       $ 3,500 $ 3,500  
License Agreement Terms [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Milestone payments $ 30,000              
Sublicense And Inventory Purchase Agreements [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Fixed consideration     $ 7,000          
Sublicense And Inventory Purchase Agreements [Member] | Event Based Milestone Payments [Member] | Maximum [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Variable consideration     26,000          
Sublicense And Inventory Purchase Agreements [Member] | Sales Based Milestone Payments [Member] | Maximum [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Variable consideration     $ 30,000          
Sublicense And Inventory Purchase Agreements [Member] | License [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Revenue recognized           0 0  
Contract assets       0   0   $ 0
Sublicense Agreement Relating to Rett Syndrome [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Fixed consideration   $ 3,000            
Sublicense Agreement Relating to Rett Syndrome [Member] | Event Based Milestone Payments [Member] | Maximum [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Variable consideration   26,500            
Sublicense Agreement Relating to Rett Syndrome [Member] | Sales Based Milestone Payments [Member] | Maximum [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Variable consideration   $ 30,000            
Sublicense Agreement Relating to Rett Syndrome [Member] | License [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Revenue recognized       $ 3,500 $ 3,500